The Relationship between Oxidative Stress, Inflammation, and Atherosclerosis in Renal Transplant and End-Stage Renal Disease Patients

REFERENCES

• Collins AJ. Cardiovascular mortality in end-stage renal disease. Am J Med Sci. 2003;325(4):163–167.
   PubMed Web of Science ®Google Scholar
• Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16(2):529–538.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62(5):1524–1538.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: How do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008; 3(2):505–521.
   PubMed Web of Science ®Google Scholar
• Turkmen K, Gorgulu N, Uysal M, . Fetuin-A, inflammation, and coronary artery calcification in hemodialysis patients. Indian J Nephrol. 2011;21(2):90–94.
   PubMedGoogle Scholar
• Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol. 2001;12(11): 2458–2464.
   PubMed Web of Science ®Google Scholar
• Horne BD, Anderson JL, John JM, . Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45(10):1638–1643.
   PubMed Web of Science ®Google Scholar
• Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102(6):653–657.
   PubMed Web of Science ®Google Scholar
• Nunez J, Nunez E, Bodi V, . Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008;101(6):747–752.
   PubMed Web of Science ®Google Scholar
• Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil–lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91(3):181–184.
   PubMed Web of Science ®Google Scholar
• Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006;97(7):993–996.
   PubMed Web of Science ®Google Scholar
• Turkmen K, Guney I, Yerlikaya FH, Tonbul HZ. The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren Fail. 2012;34(2):155–159.
   PubMed Web of Science ®Google Scholar
• Savchenko A, Imamura M, Ohashi R, . Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J Pathol. 2008;215(1):48–55.
   PubMed Web of Science ®Google Scholar
• Cieslik P, Hrycek A. Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications. Autoimmunity. 2012;45(2):119–128.
   PubMed Web of Science ®Google Scholar
• Suliman ME, Yilmaz MI, Carrero JJ, . Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. Clin J Am Soc Nephrol. 2008;3(4):976–985.
   PubMed Web of Science ®Google Scholar
• Boehme M, Kaehne F, Kuehne A, . Pentraxin 3 is elevated in hemodialysis patients and is associated with cardiovascular disease. Nephrol Dial Transplant. 2007;22(8):2224–2229.
   PubMed Web of Science ®Google Scholar
• Salio M, Chimenti S, De Angelis N, . Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation. 2008;117(8):1055–1064.
   PubMed Web of Science ®Google Scholar
• Norata GD, Marchesi P, Pulakazhi Venu VK, . Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation. 2009;120(8):699–708.
   PubMed Web of Science ®Google Scholar
• Turedi S, Cinar O, Yavuz I, . Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population. J Nephrol. 2010;23(3):335–340.
   PubMed Web of Science ®Google Scholar
• Cichota LC, Moresco RN, Duarte MM, da Silva JE. Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. J Clin Lab Anal. 2008;22(1):1–5.
   PubMed Web of Science ®Google Scholar
• Piva SJ, Duarte MM, Da Cruz IB, . Ischemia-modified albumin as an oxidative stress biomarker in obesity. Clin Biochem. 2011;44(4):345–347.
   PubMed Web of Science ®Google Scholar
• Duarte MM, Rocha JB, Moresco RN, . Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem. 2009;42(7–8):666–671.
   PubMed Web of Science ®Google Scholar
• Sharma R, Gaze DC, Pellerin D, . Ischemia-modified albumin predicts mortality in ESRD. Am J Kidney Dis. 2006;47(3):493–502.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt–albumin binding and its potential as a marker for myocardial ischemia—A preliminary report. J Emerg Med. 2000;19(4):311–315.
   PubMed Web of Science ®Google Scholar
• Levey AS, Berg RL, Gassman JJ, Hall PM, Walker WG. Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl. 1989;27:S73–S80.
   Google Scholar
• Himmelfarb J. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Semin Dial. 2009;22(6):636–643.
   PubMed Web of Science ®Google Scholar
• Bottazzi B, Garlanda C, Cotena A, . The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: Interplay with cellular innate immunity. Immunol Rev. 2009; 227(1):9–18.
   PubMed Web of Science ®Google Scholar
• Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005;23: 337–366.
   PubMed Web of Science ®Google Scholar
• Norata GD, Garlanda C, Catapano AL. The long pentraxin PTX3: A modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc Med. 2010;20(2):35–40.
   PubMed Web of Science ®Google Scholar
• Tong M, Carrero JJ, Qureshi AR, . Plasma pentraxin 3 in patients with chronic kidney disease: Associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol. 2007;2(5):889–897.
   PubMed Web of Science ®Google Scholar
• Yilmaz MI, Axelsson J, Sonmez A, . Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria. Clin J Am Soc Nephrol. 2009;4(3):535–541.
   PubMed Web of Science ®Google Scholar
• Norata GD, Marchesi P, Pirillo A, . Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol. 2008;28(5):925–931.
   PubMed Web of Science ®Google Scholar
• Deban L, Jaillon S, Garlanda C, Bottazzi B, Mantovani A. Pentraxins in innate immunity: Lessons from PTX3. Cell Tissue Res. 2011;343(1):237–249.
   PubMed Web of Science ®Google Scholar
• Arruda-Olson AM, Reeder GS, Bell MR, Weston SA, Roger VL. Neutrophilia predicts death and heart failure after myocardial infarction: A community-based study. Circ Cardiovasc Qual Outcomes. 2009;2(6):656–662.
   PubMed Web of Science ®Google Scholar
• Rudiger A, Burckhardt OA, Harpes P, Muller SA, Follath F. The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failure. Am J Emerg Med. 2006;24(4):451–454.
   PubMed Web of Science ®Google Scholar
• Hurst RT, Ng DW, Kendall C, Khandheria B. Clinical use of carotid intima–media thickness: Review of the literature. J Am Soc Echocardiogr. 2007;20(7):907–914.
   PubMed Web of Science ®Google Scholar
• Hornum M, Clausen P, Idorn T, Hansen JM, Mathiesen ER, Feldt-Rasmussen B. Kidney transplantation improves arterial function measured by pulse wave analysis and endothelium-independent dilatation in uraemic patients despite deterioration of glucose metabolism. Nephrol Dial Transplant. 2011;26(7): 2370–2377.
   PubMed Web of Science ®Google Scholar
• Seyahi N, Cebi D, Altiparmak MR, . Progression of coronary artery calcification in renal transplant recipients. Nephrol Dial Transplant. 2012;27(5):2101–2107.
   PubMed Web of Science ®Google Scholar
• Yilmaz MI, Qureshi AR, Carrero JJ, . Predictors of carotid artery intima–media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease. Am J Nephrol. 2010;31(3):214–221.
   PubMed Web of Science ®Google Scholar
• Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications. Kidney Int. 1999;55(2):389–399.
   PubMed Web of Science ®Google Scholar
• Raj DS, Choudhury D, Welbourne TC, Levi M. Advanced glycation end products: A Nephrologist’s perspective. Am J Kidney Dis. 2000;35(3):365–380.
   PubMed Web of Science ®Google Scholar
• Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: A systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63(1):102–110.
   PubMed Web of Science ®Google Scholar
• Kodama S, Saito K, Yachi Y, . Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32(9):1737–1742.
   PubMed Web of Science ®Google Scholar
• Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: A systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010; 62(2):170–180.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Huddam B, Azak A, . A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011;6(8): 1887–1894.
   PubMed Web of Science ®Google Scholar